Genex $GNX $GNX.AX a renewable energy play with battery, pumped hydro and firming capacity has gone into a trading halt to raise capital at a 40% discount to 52-week highs.
Let's take a quick look 👇
You can find the original deep dive and updates here.
And don’t forget, if you click on my profile and then go to moments/index, you will see the full library of deep dives and updates.
To be honest I was pretty happy with their recent report.
Revenue ahead of schedule for Kidston Solar ($11.5m annualized vs $10.6 expected) and Jemalong ($11.7 vs $10m ).
The most recent cap raise is to fund the Bouldercombe battery project with Tesla, and meet capital requirements. The batteries have great margins, but require a lot of CAPEX upfront - something Genex is lacking in.
Prior to the cap raise the asset valuations were looking really good. The risk was always shareholder dilution and capital requirements - but with +$600m loans from NAIF and $200m from ARENA and QldGov in grants, it seemed to be de-risked.
And here's the shareholder value destruction when you cap raise at 15c for $40m. Note EV remains the same, the change in returns is all because of diluting existing shareholders.
Still, looks like one can get decent returns. What was 35% may now be 29% CAGR.
I'll cop this lesson the hard way, though fortunately I positioned well and may look to average down if the board stops empire building on high CAPEX batteries.
Oh I should be clear on this that @abroninvestor red flagged a risk to me that I overlooked, and didn't advise or recommend. Sorry that wasn't clear.
Mike Cannon-Brookes might be pretty busy this week. So I wonder if he will have the time to participate in the next Genex $GNX.AX capital raise, at 15c vs 27c in March 2021? 🤔
The global salmon industry is in turmoil as fears of contagion of the Norwegian resource tax hits the Faroe Islands.🐟
P/F Bakkafrost $BAKKA is down another 12% overnight, while the big Norwegians $MOWI $SALM $LSG continue to slide.
Let's take a look at the Faroe Islands 🧵👇
1. Yesterday I looked at Norway's resource tax and figured it was too difficult to find a good risk/reward bet. Right now the best forecasters of European monetary and fiscal policy seem to be a random number generator. Today I'm looking at Faroe Islands.
Norway produces over 50% of the world's Atlantic salmon. So this is kind of a big deal.
Unsurprisingly, the largest salmon companies in the world are also in Norway. In fact, the four largest are from Norway. This is because they have a huge cost advantage in the cold fjords which provide better growing conditions.
Delorean's $DEL $DEL.AX update to the market has left a fair bit to be desired. Engineering division has been decimated, financing remains out of reach, though retail is doing alright. Time to hit the panic button? 🚨
Let's take a closer look 🤏🧵👇
If you don't know what Delorean is, please don't @ me, just look at the original deep dive.
Clean Seas $CSS $CSS.AX FY22 results look really good. I recently spoke with Rob Gratton (CEO) and got to understand more of their business model and strategic direction.
Here's a short thread on my thoughts and why I don't hold 🤏🧵👇
The FY22 results look very strong. Volume growth (3.7kt), ~20% increase in pricing, ~37% revenue increase, 19% reduction in production costs, etc. And for the first time, profitable! 🎯
But I have mentioned before, this is really a bull-whip effect from the diabolical FY20 which saw inventory build up etc, and now being sold in FY22.
Treasury Wine Estates $TWE $TWE.AX FY22 results came out, and they're good considering the China wine-ban is still being flushed out. Total revenues down, but margins and NPAT are both up 🍷😋
Let's take a quick look 👇
You can find my original thread here where I outlined TWE as an asset play, with the hope that profits may return in due course.
To put in perspective the FY22 results, you can see here the 1H22 results were less negative than the market expected. But 2H22 has been pretty strong, which is why NPAT is up *only* 4% but almost 10% if you annualise 2H22.